Weiss, A., Campbell, J., Ballman, K. V., Sikov, W. M., Carey, L. A., Hwang, E. S., … Golshan, M. (2021). ASO Visual Abstract: Factors Associated with Nodal Pathologic Complete Response Among Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Results of CALGB 40601 (HER2+) and 40603 (Triple-Negative) (Alliance). Ann Surg Oncol, 28(Suppl 3), 436–437. https://doi.org/10.1245/s10434-021-10005-1

Weiss, Anna, Jordan Campbell, Karla V. Ballman, William M. Sikov, Lisa A. Carey, E Shelley Hwang, Matthew M. Poppe, Ann H. Partridge, David W. Ollila, and Mehra Golshan. “ASO Visual Abstract: Factors Associated with Nodal Pathologic Complete Response Among Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Results of CALGB 40601 (HER2+) and 40603 (Triple-Negative) (Alliance).” Ann Surg Oncol 28, no. Suppl 3 (December 2021): 436–37. https://doi.org/10.1245/s10434-021-10005-1.

Weiss A, Campbell J, Ballman KV, Sikov WM, Carey LA, Hwang ES, et al. ASO Visual Abstract: Factors Associated with Nodal Pathologic Complete Response Among Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Results of CALGB 40601 (HER2+) and 40603 (Triple-Negative) (Alliance). Ann Surg Oncol. 2021 Dec;28(Suppl 3):436–7.

Weiss, Anna, et al. “ASO Visual Abstract: Factors Associated with Nodal Pathologic Complete Response Among Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Results of CALGB 40601 (HER2+) and 40603 (Triple-Negative) (Alliance).” Ann Surg Oncol, vol. 28, no. Suppl 3, Dec. 2021, pp. 436–37. Pubmed, doi:10.1245/s10434-021-10005-1.

Weiss A, Campbell J, Ballman KV, Sikov WM, Carey LA, Hwang ES, Poppe MM, Partridge AH, Ollila DW, Golshan M. ASO Visual Abstract: Factors Associated with Nodal Pathologic Complete Response Among Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Results of CALGB 40601 (HER2+) and 40603 (Triple-Negative) (Alliance). Ann Surg Oncol. 2021 Dec;28(Suppl 3):436–437.